Rare diseases
Investigational molecules
Locations
364 conditions with trials, the busiest first
1 201 trials across Europe, recruiting first
Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma
AustriaStudy on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma
GermanyStudy of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma
FranceStudy on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination
BelgiumStudy on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors
AustriaStudy Comparing Clofarabine/Busulfan and Fludarabine/Busulfan for Adults with Acute Myeloid Leukemia Eligible for Stem Cell Transplantation
FranceStudy of Venetoclax and Decitabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
GermanyStudy on Hydroxyurea and Valproic Acid or 6-Mercaptopurine with Valproic Acid for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NorwayStudy on the Effectiveness of Eltrombopag in Combination with Other Drugs for Patients with Immune Thrombocytopenia
CzechiaStudy on the Safety and Effects of Luspatercept for Children with Beta Thalassemia
GermanyStudy Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma
BelgiumStudy on [68Ga]Ga-PentixaFor PET Imaging for Better Risk and Disease Assessment in Patients with Multiple Myeloma
BelgiumThe therapies tested most often in Blood and lymphatic system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
